{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:07:04Z","timestamp":1784696824957,"version":"3.55.0"},"reference-count":22,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:00:00Z","timestamp":1641945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infectious Disease Reports"],"abstract":"<jats:p>There is limited evidence to guide successful treatment of recurrent Campylobacter infection in patients with common variable immunodeficiency (CVID) already managed on regular immunoglobulin therapy. The role of faecal microbiota transplant (FMT) is uncertain. We report a case of recurrent Campylobacter jejuni infection in a patient with CVID treated with repeated FMT with 18 months of symptom resolution prior to relapse.<\/jats:p>","DOI":"10.3390\/idr14010007","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T04:15:25Z","timestamp":1641960925000},"page":"56-62","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Recurrent Campylobacter jejuni Infection in an Immunodeficient Patient Treated with Repeated Faecal Microbiota Transplant (FMT)\u2014A Case Report"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6061-6064","authenticated-orcid":false,"given":"Blair","family":"Merrick","sequence":"first","affiliation":[{"name":"Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust and King\u2019 College, London SE1 7EH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravind Gokul","family":"Tamilarasan","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London SE1 7EH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Luber","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London SE1 7EH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick F. K.","family":"Yong","sequence":"additional","affiliation":[{"name":"Department of Immunology, Frimley Health NHS Foundation Trust, Frimley GU16 7UJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuldeep","family":"Cheent","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Frimley Health NHS Foundation Trust, Frimley GU16 7UJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Irving","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London SE1 7EH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjula","family":"Meda","sequence":"additional","affiliation":[{"name":"Department of Infection and Immunity, Frimley Health NHS Foundation Trust, Frimley GU16 7UJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0837-7382","authenticated-orcid":false,"given":"Simon D.","family":"Goldenberg","sequence":"additional","affiliation":[{"name":"Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust and King\u2019 College, London SE1 7EH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1128\/AAC.00447-16","article-title":"Potential use of fosfomycin-tromethamine for treatment of recurrent campylobacter species enteritis","volume":"60","author":"Pigrau","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s40121-018-0189-y","article-title":"Comparison of different strategies for providing fecal microbiota transplantation to treat patients with recurrent clostridium difficile infection in two English hospitals: A review","volume":"7","author":"Goldenberg","year":"2018","journal-title":"Infect. Dis. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1136\/gutjnl-2018-316818","article-title":"The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: Joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines","volume":"67","author":"Mullish","year":"2018","journal-title":"Gut"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.iac.2020.03.001","article-title":"Defining common variable immunodeficiency disorders in 2020","volume":"40","author":"Ameratunga","year":"2020","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"ref_5","first-page":"140","article-title":"Hypogammaglobulinaemia: Cumulative experience in 49 patients in a tertiary care institution","volume":"60","author":"Smits","year":"2002","journal-title":"Neth. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"712915","DOI":"10.3389\/fimmu.2021.712915","article-title":"Gut microbiome and common variable immunodeficiency: Few certainties and many outstanding questions","volume":"12","author":"Varricchi","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/BF00915550","article-title":"Incidence of cancer in 98 patients with common varied immunodeficiency","volume":"7","author":"Siegal","year":"1987","journal-title":"J. Clin. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/jac\/dkl210","article-title":"Macrolide resistance in campylobacter jejuni and campylobacter coli: Molecular mechanism and stability of the resistance phenotype","volume":"58","author":"Gibreel","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1128\/JCM.00768-10","article-title":"Caught in the act: In vivo development of macrolide resistance to campylobacter jejuni infection","volume":"48","author":"Lindow","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.trsl.2020.04.009","article-title":"New and alternative strategies for the prevention, control, and treatment of antibiotic-resistant Campylobacter","volume":"223","author":"Dai","year":"2020","journal-title":"Transl. Res."},{"key":"ref_11","unstructured":"Center for Disease Control and Prevention (2021, October 06). Campylobacter (Campylobacteriosis) > Oubreaks > Multidrug-Resistant Campylobacter Infectious Linked to Contact with Pet Store Puppies, Available online: https:\/\/www.cdc.gov\/campylobacter\/outbreaks\/puppies-12-19\/advice-to-clinicians.html."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","article-title":"Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: A randomised placebo-controlled trial","volume":"389","author":"Paramsothy","year":"2017","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.30690","article-title":"Fecal microbial transplant capsules are safe in hepatic encephalopathy: A phase 1, randomized, placebo-controlled trial","volume":"70","author":"Bajaj","year":"2019","journal-title":"Hepatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.cmi.2018.12.009","article-title":"A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: A randomized clinical trial","volume":"25","author":"Huttner","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/cid\/ciw185","article-title":"Fecal microbial transplants reduce antibiotic-resistant genes in patients with recurrent clostridium difficile infection","volume":"62","author":"Millan","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"ofy334","DOI":"10.1093\/ofid\/ofy334","article-title":"Recurrent relatively resistant salmonella infantis infection in 2 immunocompromised hosts cleared with prolonged antibiotics and fecal microbiota transplantation","volume":"6","author":"Soto","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.3748\/wjg.v23.i39.7174","article-title":"Faecal microbiota transplantation in patients with Clostridium difficile and significant comorbidities as well as in patients with new indications: A case series","volume":"23","author":"Lahtinen","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e01212","DOI":"10.1128\/mBio.01212-14","article-title":"Susceptibility to campylobacter infection is associated with the species composition of the human fecal microbiota","volume":"5","author":"Dicksved","year":"2014","journal-title":"mBio"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"61.e1","DOI":"10.1016\/j.cmi.2015.09.004","article-title":"Composition of human faecal microbiota in resistance to Campylobacter infection","volume":"22","author":"Kampmann","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/mi.2016.18","article-title":"Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation","volume":"9","author":"Kummen","year":"2016","journal-title":"Mucosal Immunol."},{"key":"ref_21","first-page":"2049936120981526","article-title":"The role of faecal microbiota transplantation: Looking beyond Clostridioides difficile infection","volume":"8","author":"Goldenberg","year":"2021","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","article-title":"Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial","volume":"149","author":"Moayyedi","year":"2015","journal-title":"Gastroenterology"}],"container-title":["Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2036-7449\/14\/1\/7\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:02:05Z","timestamp":1760364125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2036-7449\/14\/1\/7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,12]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["idr14010007"],"URL":"https:\/\/doi.org\/10.3390\/idr14010007","relation":{},"ISSN":["2036-7449"],"issn-type":[{"value":"2036-7449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,12]]}}}